A crucial element of regenerative healthcare and drug investigation lies in the ability to grow human stem cell groups to sufficient quantities for therapeutic uses. Traditionally, constrained cell availability posed a significant obstacle to development in these fields. Consequently, considerable endeavor has been directed towards improving method